Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program

Cancer

Volumn 119, Issue SUPPL. 15, 2013, Pages 2820-2833

  Seeff, Laura C ^a   Royalty, Janet ^a   Helsel, William E ^b   Kammerer, William G ^b   Boehm, Jennifer E ^a   Dwyer, Diane M ^c   Howe, William R ^b   Joseph, Djenaba ^a   Lane, Dorothy S ^d   Laughlin, Melinda ^e   Leypoldt, Melissa ^f   Marroulis, Steven C ^b   Mattingly, Cynthia A ^b   Nadel, Marion R ^a   Phillips Angeles, Ellen ^g   Rockwell, Tanner J ^b   Ryerson, A Blythe ^a   Tangka, Florence K L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^e MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^f Nebraska Dept of Correctional Serv   (United States)

^g PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

Author keywords

cancer screening programs; colonoscopy; colorectal cancer prevention; colorectal cancer screening; fecal occult blood testing

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL ASSESSMENT; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; FEMALE; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; INCIDENCE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REPEAT PROCEDURE; RISK ASSESSMENT; SCREENING TEST; TUMOR INVASION; UNITED STATES;

EID: 84880522695     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28163     Document Type: Article

References (55)

1. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2011. Available at: www.cdc.gov/uscs. Accessed June 10, 2013.
2. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544-573.
3. Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS,. Colorectal cancer incidence in the United States 1999-2004: an updated analysis of data from the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program. Cancer. 2009; 115: 1967-1976.
4. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML,. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103: 117-128.
5. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329: 1977-1981.
6. Agency for Healthcare Research and Quality (AHRQ). Screening for Colorectal Cancer: Recommendation Statement. AHRQ publication no. 08-05124-EF-3. Rockville, MD: AHRQ, US Department of Health and Human Services; 2008. Available at: http://www.ahrq.gov/clinic/uspstf08/colocancer/colors.htm. Accessed June 30, 2010.
7. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343: 1603-1607.
8. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993; 328: 1365-1371.
9. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS,. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992; 326: 653-657.
10. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM,. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992; 84: 1572-1575.
11. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.
12. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O,. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348: 1467-1471.
13. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010; 375: 1624-1633.
14. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers, N Engl J Med. 2008; 359: 1207-1217.
15. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 884-889.
16. Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW,. Colorectal Cancer test use from the 2005 National Health Interview Survey. Epidemiol Biomarkers Prev. 2008; 17: 1623-1630.
17. Rim SH, Joseph DA, Steele, CB, Thompson TD, Seeff LC,; Centers for Disease Control and Prevention (CDC). Colorectal Cancer Screening-United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ. 2011; 60 (suppl 15): 42-46.
18. Seeff LC, DeGroff A, Tangka F, et al. Development of a federally funded demonstration colorectal cancer screening program [serial online]. Prev Chronic Dis. 2008; 5: A64.
19. DeGroff A, Holden D, Goode Green S, Boehm J, Seeff LC, Tangka F,. Start-up of the colorectal cancer screening demonstration project [serial online]. Prev Chronic Dis. 2008; 5A38.
20. DeGroff A, Boehm J, Green SG, Holden D, Seeff LC,. Facilitators and challenges to start-up of the colorectal cancer screening demonstration program [serial online]. Prev Chronic Dis. 2008; 5: A39.
21. Tangka FKL, Subramanian S, Bapat B, Seeff LC, et al. Cost of starting colorectal cancer screening programs: results from 5 federally funded demonstration programs [serial online]. Prev Chronic Dis. 2008; 5: A47.
22. Centers for Disease Control and Prevention (CDC). The National Breast and Cervical Early Detection Program. 1991-2002 National Report. Atlanta, GA: US Department of Health and Human Services; 2005.
23. Subramanian S, Tangka FKL, Hoover S, et al. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (suppl 15): 2855-2862.
24. Villanueva, et al. Collaborating across multiple health care institutions in an urban colorectal cancer screening program. Cancer. 2013; 119 (suppl 15): 2905-2913.
25. Lane DS, Messina CR, Cavanagh MF, Anderson JC,. Delivering colonoscopy screening for low-income populations in Suffolk County: strategies, outcomes, and benchmarks. Cancer. 2013; 119 (suppl 15): 2842-2848.
26. Cavanagh MF, Lane DS, Messina CR, Anderson JC,. Clinical case management and navigation for colonoscopy screening in an academic medical center. Cancer. 2013; 119 (suppl 15): 2894-2904.
27. Phillips-Angeles E, Song L, Hannon PA, et al. Fostering partnerships and program success. Cancer. 2013; 119 (suppl 15): 2884-2893.
28. Boehm JE, Rohan EA, Preissle J, DeGroff A, Glover-Kudon R,. Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program: strategies and challenges across 5 sites. Cancer. 2013; 119 (suppl 15): 2914-2925.
29. Castro G, Seeff L, Azrak F, et al. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis. Cancer. 2013; 119 (suppl 15): 2849-2854.
30. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002; 137: 129-131.
31. Nadel, et al. Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (suppl 15): 2834-2841.
32. Glover-Kudon R, DeGroff A, Rohan EA, Preissle J, Boehm J,. Developmental milestones across the programmatic life cycle: implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (suppl 15): 2926-2939.
33. Rohan EA, Boehm JE, DeGroff A, Glover-Kudon R, Preissle J,. Implementing the CDC's Colorectal Cancer Screening Demonstration Program: wisdom from the field. Cancer. 2013; 119 (suppl 15): 2870-2883.
34. Tangka FKL, Subramanian S, Beebe MC, Hoover S, Royalty J, Seeff LC,. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs. Cancer. 2013; 119 (suppl 15): 2863-2869.
35. Benson VS, Atkin WS, Green J, et al. International Colorectal Cancer Screening Network. Towards standardizing and reporting colorectal cancer screening indicators on an international level: the International Colorectal Cancer Screening Network, Int J Cancer. 2012; 130: 2961-2973.
36. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006; 56: 143-159.
37. Rimer BK, Conaway M, Lyna P, Glassman B, Yarnall KS, Lipkus I, Barber LT,. The impact of tailored interventions on a community health center population. Patient Educ Couns. 1999; 37: 125-140.
38. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G,. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000; 343: 162-168; erratum in N Engl J Med. 2000; 34:1204.
39. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF,. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000; 343: 169-174.
40. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF,. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002; 346: 1781-1785.
41. Gupta S, Saunders BP, Fraser C, et al. The first 3 years of national bowel cancer screening at a single UK tertiary centre. Colorectal Dis. 2012; 14: 166-173.
42. Lisi D, Hassan CC, Crespi M,; AMOD Study Group. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. Dig Liver Dis. 2010; 42: 371-376.
43. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010; 59: 62-68.
44. Lieberman D, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007; 65: 757-766.
45. Li J, Nadel MR, Poppell CF, Dwyer DM, Lieberman DA, Steinberger EK,. Quality assessment of colonoscopy reporting: results from a statewide cancer screening program [serial online]. Diagn Ther Endosc 2010: 419796, 2010.
46. Thompson L, Reeder T, Abel G,. I can't get my husband to go and have a colonoscopy: gender and screening for colorectal cancer. Health (London). 2012; 16: 235-249.
47. Kelly B, Hornik R, Romantan A, et al. Cancer information scanning and seeking in the general population. J Health Commun. 2010; 15: 734-753.
48. Rutten LJ, Squiers L, Hesse B,. Cancer-related information seeking: hints from the 2003 Health Information National Trends Survey (HINTS). J Health Commun. 2006; 11 (suppl 1): 147-156.
49. Griffith DM, Gunter K, Allen JO,. Male gender role strain as a barrier to African American men's physical activity. Health Educ Behav. 2011; 38: 482-491.
50. Cafferty FH, Wong JM, Yen AM, Duffy SW, Atkin WS, Chen TH,. Findings at follow-up endoscopies in subjects with suspected colorectal abnormalities: effects of baseline findings and time to follow-up. Cancer J. 2007; 13: 263-270.
51. Hol L, de Bekker-Grob EW, van Dam L, et al. Preferences for colorectal cancer screening strategies: a discrete choice experiment. Br J Cancer. 2010; 102: 972-980.
52. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C,. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011; 33: 101-110.
53. Seeff LC, Manninen D, Dong F, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004; 127: 1661-1669.
54. Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's Survey of Endoscopic Capacity. Gastroenterology. 2004; 127: 1670-1677.
55. 111th Congress of the United States. The Patient Protection and Affordable Care Act. Pubic Law No. 111-148.